Profile data is unavailable for this security.
About the company
RedHill Biopharma Ltd is an Israel-based specialty biopharmaceutical company primarily focused on gastrointestinal and infectious diseases. RedHill promotes the gastrointestinal drugs such as, Talicia for the treatment of Helicobacter pylori (H. pylori) infection, and Aemcolo, for the treatment of travelers’ diarrhea. RedHill’s clinical late-stage development programs include: :info: RHB-204, for pulmonary nontuberculous mycobacteria (NTM) disease; opaganib (ABC294640), host-directed, SPHK2 inhibitor targeting multiple indications, RHB-107 (upamostat), an oral, host-directed serine protease inhibitor with potential for pandemic preparedness, is in late-stage development for treatment of non-hospitalized symptomatic COVID-19, and is targeting multiple other cancer and inflammatory gastrointestinal diseases; RHB-104 for Crohn's disease; and RHB-102 for chemotherapy and radiotherapy induced nausea and vomiting.
- Revenue in USD (TTM)9.55m
- Net income in USD-9.31m
- Incorporated2009
- Employees35.00
- LocationRedhill Biopharma Ltd21 Ha'arba'a St.TEL AVIV-YAFO 6473921IsraelISR
- Phone+972 35413131
- Fax+972 35413144
- Websitehttps://www.redhillbio.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PRF Technologies Ltd | 0.00 | -4.09m | 2.62m | 2.00 | 0.0111 | 0.1593 | -- | -- | 301.27 | 301.27 | 0.00 | 20.97 | 0.00 | -- | -- | 0.00 | -57.27 | -71.03 | -118.06 | -84.02 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -56.12 | -- | -- | -- |
| SOHM Inc | -100.00bn | -100.00bn | 2.71m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Jaguar Health Inc | 11.79m | -40.29m | 2.80m | 49.00 | -- | 0.7234 | -- | 0.2374 | -54.06 | -54.06 | 12.98 | 1.53 | 0.2184 | 0.2099 | 8.78 | 240,510.20 | -76.04 | -90.27 | -152.77 | -144.36 | 81.92 | 75.33 | -348.22 | -458.25 | 0.5197 | -4.62 | 0.8759 | -- | 19.75 | 15.14 | 6.80 | -- | -- | -- |
| China Pharma Holdings Inc | 4.05m | -3.19m | 3.16m | 224.00 | -- | 0.3806 | -- | 0.7808 | -1.10 | -1.10 | 1.28 | 1.66 | 0.2769 | 2.17 | 14.52 | 18,090.54 | -21.80 | -18.69 | -35.67 | -37.95 | -10.94 | -1.14 | -78.72 | -44.96 | 0.1026 | -30.50 | 0.2884 | -- | -35.41 | -16.15 | -53.84 | -- | 16.49 | -- |
| Functional Brands Inc | 6.80m | -377.56k | 3.26m | 32.00 | -- | 2.34 | -- | 0.4803 | -0.0546 | -0.0546 | 0.9614 | 0.0854 | 0.8873 | 0.3527 | 37.24 | 212,408.80 | -4.93 | -- | -9.96 | -- | 91.06 | -- | -5.55 | -- | 0.4419 | -0.8723 | 0.6346 | -- | -3.72 | -- | 54.93 | -- | -- | -- |
| 60 Degrees Pharmaceuticals Inc | 1.35m | -8.48m | 4.13m | 3.00 | -- | -- | -- | 3.05 | -23.04 | -23.04 | 2.93 | 4.32 | 0.1919 | 1.59 | 2.71 | 451,383.30 | -113.08 | -- | -148.26 | -- | 42.47 | -- | -589.17 | -- | 2.63 | -44.07 | 0.0342 | -- | 168.70 | -- | -111.48 | -- | -- | -- |
| Sonoma Pharmaceuticals Inc | 17.72m | -3.37m | 4.90m | 168.00 | -- | 1.43 | -- | 0.2764 | -2.04 | -2.04 | 10.72 | 1.98 | 1.30 | 3.20 | 7.40 | 105,488.10 | -24.70 | -29.32 | -34.79 | -40.47 | 38.16 | 36.22 | -19.02 | -32.35 | 2.00 | -- | 0.00 | -- | 12.19 | -4.44 | 28.50 | -- | -17.24 | -- |
| RedHill Biopharma Ltd (ADR) | 9.55m | -9.31m | 5.22m | 35.00 | -- | -- | -- | 0.5461 | -6.40 | -6.40 | 6.29 | -1.32 | 0.4728 | 0.9738 | 3.02 | 272,857.20 | -46.11 | -39.01 | -- | -114.48 | 64.45 | 48.52 | -97.52 | -101.52 | 0.4211 | -- | -- | -- | 23.17 | 5.04 | -134.57 | -- | -46.38 | -- |
| LakeShore Biopharma Co Ltd | 89.02m | -14.47m | 5.33m | 573.00 | -- | 0.0371 | 0.801 | 0.0599 | -0.749 | -0.749 | 4.65 | 3.48 | 0.427 | 0.5001 | 1.30 | 155,360.70 | -6.94 | -- | -15.95 | -- | 82.47 | -- | -16.26 | -- | 0.7452 | -2.63 | 0.453 | -- | 7.24 | -- | 76.93 | -- | -- | -- |
| Sunshine Biopharma Inc | 37.32m | -5.99m | 5.69m | 52.00 | -- | 0.2185 | -- | 0.1525 | -2.03 | -2.03 | 10.74 | 5.31 | 1.21 | 2.09 | 10.12 | 717,764.30 | -19.47 | -68.65 | -23.80 | -89.02 | 33.01 | 32.79 | -16.06 | -81.12 | 2.09 | -209.95 | 0.00 | -- | 44.75 | 340.11 | -13.94 | -- | 370.33 | -- |
| Nutraproducts Inc | 0.00 | -821.94k | 7.08m | 0.00 | -- | 1.18 | -- | -- | -1.31 | -1.31 | 0.00 | 0.2973 | 0.00 | -- | -- | -- | -513.70 | -1,177.23 | -740.45 | -- | -- | -- | -- | -- | -- | -385.17 | 0.00 | -- | -- | -- | -- | -- | -- | -- |
Data as of Feb 18 2026. Currency figures normalised to Redhill Biopharma Ltd's reporting currency: US Dollar USD
14.53%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Yorkville Advisors Global LPas of 31 Dec 2025 | 386.59k | 11.61% |
| Gagnon Securities LLCas of 31 Dec 2025 | 86.10k | 2.59% |
| GAMMA Investing LLCas of 31 Dec 2025 | 4.83k | 0.15% |
| Desjardins Securities, Inc.as of 31 Dec 2025 | 3.39k | 0.10% |
| RhumbLine Advisers LPas of 31 Dec 2025 | 2.68k | 0.08% |
| Merrill Lynch, Pierce, Fenner & Smith, Inc. (Invt Mgmt)as of 30 Sep 2025 | 303.00 | 0.01% |
| EverSource Wealth Advisors LLCas of 31 Dec 2025 | 38.00 | 0.00% |
| Your Advocates Ltd. LLPas of 31 Dec 2025 | 19.00 | 0.00% |
| UBS Switzerland AG (Investment Management)as of 31 Dec 2025 | 16.00 | 0.00% |
| Smartleaf Asset Management LLCas of 31 Dec 2025 | 5.00 | 0.00% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
